SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Merge Healthcare, Incorporated to Contact Brower Piven Before the March 17, 2014 Lead Plaintiff Deadline -- MRGE

STEVENSON, Md., March 7, 2014 (GLOBE NEWSWIRE) -- Brower Piven, A Professional Corporation announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of Illinois on behalf of purchasers of Merge Healthcare, Incorporated, ("Merge Healthcare" or the "Company") (Nasdaq:MRGE) common stock during the period between August 1, 2012 and January 17, 2014, inclusive (the "Class Period").

If you are a shareholder who purchased Merge Healthcare common stock during the Class Period, you may obtain additional information about this lawsuit and your ability to become a lead plaintiff, at no cost to you, by contacting Brower Piven at, by email at, by calling 410/415-6616, or at Brower Piven, A Professional Corporation, 1925 Old Valley Road, Stevenson, Maryland 21153. Attorneys at Brower Piven have combined experience litigating securities and class action cases of over 60 years.

No class has yet been certified in the above action. Members of the Class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. If you wish to choose counsel to represent you and the Class, you must apply to be appointed lead plaintiff no later than March 17, 2014 and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement and how much of a settlement to accept for the Class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in Company units during the Class Period.

The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants' failure to disclose during the Class Period that both the existence and value of millions of dollars of the Company's eClinical customer contracts had been falsified, and as a result the Company's reported subscription backlog was overstated during the six quarters ended September 30, 2013, and that the Company was experiencing a continued reluctance amongst large health systems to move forward with enterprise imaging purchases.

According to the complaint, following the Company's disclosures in May 2013 regarding the sudden resignation of the Company's General Counsel and later its Chairman and CEO, and the release of "very disappointing" second quarter 2013 earnings results and a January 8, 2014 announcement that the existence and/or value of millions of dollars of customer contracts had been falsified for six quarters ending September 30, 2013, ending September 30, 2013, in what it characterized as a rogue employee's attempt to reach sales quotas and garner additional commissions, the value of Merge Healthcare shares declined significantly.

If you choose to retain counsel, you may retain Brower Piven without financial obligation or cost to you, or you may retain other counsel of your choice. You need take no action at this time to be a member of the class.

CONTACT: Charles J. Piven Brower Piven, A Professional Corporation Stevenson, Maryland 410/415-6616 hoffman@browerpiven.comSource: Brower Piven, A Professional Corporation